Stay updated with breaking news from Lobe Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vancouver, British Columbia--(Newsfile Corp. - September 8, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering
The Dow closed Thursday up 146 points, 0.5%, at 31,656, while the Nasdaq Composite lost 31 points, 0.3%, to 11,785 and the S&P 500 added 12...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Psychedelics biopharma company Lobe Sciences Ltd. (OTCQB:LOBEF) signed a deal with Cantheon Capital, a development of cannabinoids and psyche...
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires